Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97252322 | 9725232 | 2 | F | 20160726 | 20131203 | 20160809 | EXP | CA-RANBAXY-2013US-75763 | RANBAXY | GYSEL M, VIEWEG WV, HASNAIN M, HANCOX JC, KUNANITHY V, BARANCHUK A. TORSADES DE POINTES FOLLOWING CLARITHROMYCIN TREATMENT. EXPERT REV CARDIOVASC THER. 2013;NOV;11(11):1485-93 | 75.00 | YR | F | Y | 0.00000 | 20160809 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97252322 | 9725232 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Unknown | 500 MG, BID | Y | 65382 | 500 | MG | Q12H | ||||||
| 97252322 | 9725232 | 2 | SS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Intravenous (not otherwise specified) | 1 G, QD | Y | 0 | 1 | G | |||||||
| 97252322 | 9725232 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 10 MG, DAILY | U | 0 | 10 | MG | |||||||
| 97252322 | 9725232 | 4 | C | CEFTRIAXONE. | CEFTRIAXONE | 1 | Intravenous (not otherwise specified) | 2 G, QD | U | 0 | 2 | G | |||||||
| 97252322 | 9725232 | 5 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | 40 MG, DAILY | U | 0 | 40 | MG | |||||||
| 97252322 | 9725232 | 6 | C | HEPARIN | HEPARIN SODIUM | 1 | Unknown | 5000 U, BID | U | 0 | Q12H | ||||||||
| 97252322 | 9725232 | 7 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Unknown | 25 MG, QID | U | 0 | 25 | MG | Q6H | ||||||
| 97252322 | 9725232 | 8 | C | Losartan/HCT | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Unknown | 100 MG/25 MG DAILY | U | 0 | |||||||||
| 97252322 | 9725232 | 9 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Unknown | 25 MG, BID | 0 | 25 | MG | Q12H | |||||||
| 97252322 | 9725232 | 10 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | 75 MG, DAILY | U | 0 | 75 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 97252322 | 9725232 | 1 | Pneumonia |
| 97252322 | 9725232 | 2 | Pneumonia |
| 97252322 | 9725232 | 3 | Product used for unknown indication |
| 97252322 | 9725232 | 4 | Pneumonia |
| 97252322 | 9725232 | 5 | Product used for unknown indication |
| 97252322 | 9725232 | 6 | Product used for unknown indication |
| 97252322 | 9725232 | 7 | Product used for unknown indication |
| 97252322 | 9725232 | 8 | Product used for unknown indication |
| 97252322 | 9725232 | 9 | Product used for unknown indication |
| 97252322 | 9725232 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 97252322 | 9725232 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 97252322 | 9725232 | Cardiac arrest | |
| 97252322 | 9725232 | Drug-disease interaction | |
| 97252322 | 9725232 | Electrocardiogram QT prolonged | |
| 97252322 | 9725232 | Torsade de pointes |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |